Figure 1.
OS at 5 years for patients with TCL and NK/TCL enrolled in COMPLETE relative to people with HIV with TCL and NK/TCL and A-BCL enrolled in NA-ACCORD. Kaplan-Meier analysis of (A) OS for all mature patients with TCL and NK/TCL with and without HIV, (B) OS for all patients with ALCL with and without HIV, (C) OS for all patients with TCL and NK/TCL stratified by CD4 cell count in cells/µL and viral load in copies/mL, and (D) OS for all mature patients with TCL and NK/TCL and A-BCLs stratified by subtype.

OS at 5 years for patients with TCL and NK/TCL enrolled in COMPLETE relative to people with HIV with TCL and NK/TCL and A-BCL enrolled in NA-ACCORD. Kaplan-Meier analysis of (A) OS for all mature patients with TCL and NK/TCL with and without HIV, (B) OS for all patients with ALCL with and without HIV, (C) OS for all patients with TCL and NK/TCL stratified by CD4 cell count in cells/µL and viral load in copies/mL, and (D) OS for all mature patients with TCL and NK/TCL and A-BCLs stratified by subtype.

Close Modal

or Create an Account

Close Modal
Close Modal